Objective: Supraglottic hyperfunction is a compensatory behavior that occurs in patients with glottic incompetency. It is pronounced in unilateral vocal fold immobility (UVFI), where false vocal folds (FVF) can obfuscate evaluation of the true vocal folds. We sought to characterize supraglottic hyperfunction patterns in post-surgical UVFI patients.
Method: Videostroboscopy examinations of 10 consecutive post-surgical patients with complete UVFI diagnosed within 3 months of surgery were reviewed by 2 blinded, independent reviewers. Characteristics of supraglottic hyperfunction were scored for direction (AP or lateral) and whether laterality was asymmetric relative to UVFI (primary outcome). Kappa tests measured interrater reliability.
Results: The UVFI cohort was evaluated a median of 63.5 days postsurgery. UVFI was left-sided in 6 out of 10 patients. All patients had asymmetric lateral FVF hyperfunction with predominant medial excursion by the FVF contralateral to the immobile vocal fold (kappa = 1, P < .01). AP hyperfunction occurred in 1 out of 2 of cases, with its significance less agreed upon by reviewers (kappa = 0.4, P = .09). Petiole deviation toward the immobile vocal fold occurred in 70% of cases (kappa = 1, P < .01).
Conclusion: Supraglottic hyperfunction was universal in patients with UVFI. The most common pattern was 1) asymmetric lateral FVF hyperfunction with maximum medial excursion of the contralateral FVF, and 2) petiole deviation toward the side of UVFI. Understanding fiberoptic examinations of UVFI may aid our diagnostic accuracy in lesser vocal fold pareses.
Laryngology/Broncho-Esophagology Symptoms in Eosinophilic Esophagitis: a Longitudinal Study
Helen M. Larsson, MD (presenter); Karin H. Knutsson; Henrik Bergquist, MD, PhD; Mogens Bove, MD, PhD Objective: Evaluate dysphagia and health-related quality of life (HRQL) in adults newly diagnosed with eosinophilic esophagitis (EoE) at diagnosis, after 2 months of treatment with topical corticosteroid, and at least 1 year later.
Method: Between February 2008 and November 2010, 39 consecutive patients were prospectively included at a university hospital and a secondary referral hospital. The questionnaires used for evaluation were the Watson Dysphagia Scale (WDS), the EORTC QLQ-OES18 and the Short Form-36 (SF-36). The Wilcoxon signed-rank test was used to compare scores.
Results: At inclusion, the mean scores of the WDS, the EORTC QLQ-OES18 dysphagia scale and eating scale and the SF-36 global health score were 19.1, 14.5, 35.1, and 71.2, respectively. After treatment the scores improved to 9.4 (P .0004), 4.9 (P .02), 18.9 (P .01), and 74.4 (ns). At the second followup (mean 2.5 years after inclusion), the corresponding scores, 12.9 (P .01), 7.6 (P .08), 20.4 (P .02), and 76.0 (ns), were still improved compared to at inclusion. While 16 patients had a history of hospitalization due to esophageal bolus impaction, no such event occurred during the study period.
Conclusion: Newly diagnosed, untreated adult EoE is associated with a substantial burden of symptoms and impaired HRQL, which improve significantly after treatment. A partial remission is still noted more than two and a half years after diagnosis.
Laryngology/Broncho-Esophagology tyramine-Based Hyaluronan as a tracheal Cartilage Substitute
Peter C. Revenaugh, MD (presenter); Rahul Seth, MD; Anthony Calabro, MD, PhD; Daniel Knott, MD Objective: To investigate and characterize a novel tyraminebased hyaluronan/gelatin (THA/G) composite material. First, we demonstrate the ability of THA/G to adhere and maintain respiratory epithelial cells in an in vitro model. Second, we assess the feasibility of THA/G as a biologic cartilage substitute in a rabbit model of tracheal reconstruction.
Method: Immortalized human tracheal epithelial cells were grown on various concentrations of THA/G composites in vitro. Cricotracheal resection with replacement by THA/G was performed in 4 New Zealand white rabbits with auricular cartilage as control in 2 animals. Tracheal patency, graft retention, and mucosalization were evaluated via endoscopy, imaging, and histopathology.
Results: Epithelial cell growth was demonstrated on THA/G composites in vitro. In the rabbit model, all composites remained intact within the tracheal resection. However, the limited shear strength of the THA/G posed difficulties in securing the construct. At 3 and 6 weeks postimplantation, composites revealed minimal histologic evidence of macrophage or lymphocyte infiltration and were without apparent degradation. Tracheal lumen diameter was preserved in all animals. No experimental animals had evidence of dynamic airway collapse or chondromalacia. On endoscopy, there was no evidence of tracheal inflammation or granulation. However, at 6 weeks there was limited respiratory mucosa present on histology.
Conclusion: THA/G composites are a promising material for cartilage substitution. We demonstrate an ability to support epithelial cells and maintain tracheal structure. Improvements to increase the material's shear strength are necessary so that it may have potential as an airway cartilage substitute.
